La catena delle opzioni mostra i dati chiave delle opzioni azionarie di ECD Automotive Design a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per ECD Automotive Design..

ECD Automotive Design (NASDAQ:ECDA) Azioni, Catena delle Opzioni

ECD Automotive Design

ECD Automotive Design Inc is a custom-car builder in the Restomod sector with a focus on British classic motor vehicles of various models of both two-door and four-door styles. The company has established a facility geared towards producing the majority customized Land Rovers with the highest quality of parts and the highest quality labor force building each vehicle. ECD restores Land Rovers Defenders, Land Rover Series IIA, the Range Rover Classic and the Jaguar E-Type. It upgrade any engine, including Chevrolet V8's, Land Rover V8's, Cummins diesel engines and new electric drivetrains, performing all the necessary body work, drivetrain selection and installation, every stitch in the interior, paint work, up to placement of the last nut and bolt.

ECD Automotive Design, Inc. - Common Stock

ECD Automotive Design Inc

<p>Wells Fargo  analyst Larry Biegelsen   maintains Edwards Lifesciences (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>) with a Overweight and raises the price target from $80 to $84.</p>


News

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on Edwards Lifesciences, Raises Price Target to $84

<p>Evercore ISI Group  analyst Daniel Markowitz   maintains West Pharmaceutical Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WST#NYSE">WST</a>) with a Outperform and raises the price target from $275 to $350.</p>


Evercore ISI Group Maintains Outperform on West Pharmaceutical Servs, Raises Price Target to $350

<p>Shares of <strong>MARA Holdings Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) are trading lower Friday, falling nearly 3% after the <strong>Bitcoin</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) mining giant this week announced a significant capital raise.</p>
<p><strong>What To Know:</strong> The company <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46574013/why-is-marathon-raising-1b-without-paying-interest-the-real-bet-behind-its-bold-bitcoin-move">revealed</a> plans for a private offering of $850 million in 0.00% convertible senior notes due 2032, with an option for institutional buyers to purchase an additional $150 million.</p>
<p>The move, which could raise up to $1 billion, is intended to strengthen Marathon's financial position. The company plans to use approximately $50 million of the proceeds to repurchase a portion of its 1.00% convertible notes due in 2026, reducing near-term debt. </p>
<p>The <a href="https://www.benzinga.com/markets/equities/25/07/46627100/mara-holdings-stock-fell-nearly-3-in-friday-pre-market-whats-going-on">remaining funds</a> are earmarked for acquiring more Bitcoin, funding operations, and potential strategic investments. To mitigate potential shareholder dilution from the conversion of these notes, Marathon will use part of the proceeds for capped call transactions.</p>
<p>Despite the stock's <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46569958/mara-holdings-stock-is-moving-lower-wednesday-heres-why">negative reaction</a>, which is common with debt offerings, there was a note of optimism. Compass Point analyst Ed Engel upgraded MARA on Friday from Sell to Neutral and nearly doubled the price target from $9.50 to $18.</p>
<p>Investors are now looking ahead to Marathon's second-quarter financial results, scheduled for release on July 29. The company, which holds nearly 50,000 BTC, remains a key player for investors seeking exposure to the cryptocurrency market.</p>
<p><strong>Price Action:</strong> According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, MARA shares are trading lower by 2.8% to $16.77 Friday morning. The stock has a 52-week high of $30.28 and a 52-week low of $9.81.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46627515/bitcoin-slips-below-117000-on-whale-selling-ethereum-xrp-hold-steady">Bitcoin Slips Below $117,000 On Whale Selling, Ethereum, XRP Hold Steady</a></strong></p>
<h2 class="wp-block-heading">How To Buy MARA Stock</h2>
<p>Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. </p>
<p>For example, in MARA Holdings&#8217; case, it is in the Information Technology sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.</p>
<p><em>Image: Shutterstock</em></p>


$BTC

MARA

MARA Holdings Stock Slips On $1 Billion Note Offering, Analyst Upgrade Offers Support

<p>Wells Fargo  analyst Stephen Baxter   maintains UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) with a Overweight and lowers the price target from $351 to $306.</p>


Wells Fargo Maintains Overweight on UnitedHealth Group, Lowers Price Target to $306

<p>Evercore ISI Group  analyst Steve Sakwa   maintains Veris Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRE#NYSE">VRE</a>) with a In-Line and raises the price target from $17.5 to $18.</p>


Evercore ISI Group Maintains In-Line on Veris Residential, Raises Price Target to $18

<p>Wedbush  analyst Daniel Ives   reiterates Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) with a Outperform and maintains $600 price target.</p>


Reiteration

MSFT

Wedbush Reiterates Outperform on Microsoft, Maintains $600 Price Target

<p>Evercore ISI Group  analyst Jonathan Chappell   maintains Union Pacific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNP#NYSE">UNP</a>) with a In-Line and lowers the price target from $244 to $238.</p>


Evercore ISI Group Maintains In-Line on Union Pacific, Lowers Price Target to $238

<p>Wells Fargo  analyst Elyse Greenspan   maintains Globe Life (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GL#NYSE">GL</a>) with a Overweight and raises the price target from $144 to $150.</p>


Wells Fargo Maintains Overweight on Globe Life, Raises Price Target to $150

<p><strong>Universal Health Servs</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) is set to give its latest quarterly earnings report on Monday, 2025-07-28. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Universal Health Servs will report an <strong>earnings per share</strong> (EPS) of $4.90. </p>
<p>Investors in Universal Health Servs are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Performance in Previous Earnings</h3>
<p>Last quarter the company beat EPS by $0.50, which was followed by a 0.6% drop in the share price the next day.</p>
<p>Here's a look at Universal Health Servs's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>4.34</td>
<td>4.18</td>
<td>3.70</td>
<td>3.28</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>4.84</td>
<td>4.92</td>
<td>3.71</td>
<td>4.31</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-1.0%</td>
<td>3.0%</td>
<td>-10.0%</td>
<td>10.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753452164_0.png" alt="eps graph" /></p>
<h3>Market Performance of Universal Health Servs's Stock</h3>
<p>Shares of Universal Health Servs were trading at $155.46 as of July 24. Over the last 52-week period, shares are down 28.51%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. </p>
<h3>Insights Shared by Analysts on Universal Health Servs</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Universal Health Servs.</p>
<p>With 3 analyst ratings, Universal Health Servs has a consensus rating of Neutral. The average one-year price target is $214.33, indicating a potential 37.87% upside.</p>
<h3>Analyzing Analyst Ratings Among Peers</h3>
<p>The analysis below examines the analyst ratings and average 1-year price targets of Encompass Health, Ensign Group and Tenet Healthcare, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Encompass Health, with an average 1-year price target of $132.0, suggesting a potential 15.09% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Ensign Group, with an average 1-year price target of $156.0, suggesting a potential 0.35% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Tenet Healthcare, with an average 1-year price target of $194.65, suggesting a potential 25.21% upside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
<p>The peer analysis summary outlines pivotal metrics for Encompass Health, Ensign Group and Tenet Healthcare, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Universal Health Services</td>
<td>Neutral</td>
<td>6.66%</td>
<td>$3.70B</td>
<td>4.71%</td>
</tr>
<tr>
<td>Encompass Health</td>
<td>Outperform</td>
<td>10.59%</td>
<td>$630.90M</td>
<td>7.17%</td>
</tr>
<tr>
<td>Ensign Group</td>
<td>Outperform</td>
<td>16.12%</td>
<td>$188.12M</td>
<td>4.27%</td>
</tr>
<tr>
<td>Tenet Healthcare</td>
<td>Outperform</td>
<td>0.92%</td>
<td>$4.32B</td>
<td>7.26%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Universal Health Services ranks in the middle for Consensus rating among its peers. It is at the bottom for Revenue Growth. It is at the top for Gross Profit. It is in the middle for Return on Equity.</p>
<h3>Get to Know Universal Health Servs Better</h3>
<p>Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.</p>
<h3>Breaking Down Universal Health Servs's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Universal Health Servs showcased positive performance, achieving a revenue growth rate of <strong>6.66%</strong> as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.</p>
<p><strong>Net Margin:</strong> Universal Health Servs's net margin excels beyond industry benchmarks, reaching <strong>7.72%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Universal Health Servs's ROE excels beyond industry benchmarks, reaching <strong>4.71%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Universal Health Servs's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>2.16%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.75</strong>, Universal Health Servs adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<p><a href="https://www.benzinga.com/quote/UHS/earnings"><strong>To track all earnings releases for Universal Health Servs visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

What's Next: Universal Health Servs's Earnings Preview

<p>Revvity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVTY#NYSE">RVTY</a>) is gearing up to announce its quarterly earnings on Monday, 2025-07-28. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Revvity will report an <strong>earnings per share</strong> (EPS) of $1.14.</p>
<p>Anticipation surrounds Revvity's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Performance in Previous Earnings</h3>
<p>The company's EPS beat by $0.06 in the last quarter, leading to a 0.42% drop in the share price on the following day.</p>
<p>Here's a look at Revvity's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.95</td>
<td>1.38</td>
<td>1.13</td>
<td>1.12</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.01</td>
<td>1.42</td>
<td>1.28</td>
<td>1.22</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-0.0%</td>
<td>-1.0%</td>
<td>1.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753452153_0.png" alt="eps graph" /></p>
<h3>Tracking Revvity's Stock Performance</h3>
<p>Shares of Revvity were trading at $101.97 as of July 24. Over the last 52-week period, shares are down 18.84%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Analyst Opinions on Revvity</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Revvity.</p>
<p>Revvity has received a total of 7 ratings from analysts, with the consensus rating as Buy. With an average one-year price target of $115.71, the consensus suggests a potential 13.47% upside.</p>
<h3>Analyzing Analyst Ratings Among Peers</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of Medpace Hldgs, Tempus AI and Avantor, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Medpace Hldgs, with an average 1-year price target of $412.0, suggesting a potential 304.04% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Tempus AI, with an average 1-year price target of $69.67, suggesting a potential 31.68% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Avantor, with an average 1-year price target of $15.83, suggesting a potential 84.48% downside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for Medpace Hldgs, Tempus AI and Avantor, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Revvity</td>
<td>Buy</td>
<td>2.28%</td>
<td>$375.55M</td>
<td>0.55%</td>
</tr>
<tr>
<td>Medpace Hldgs</td>
<td>Neutral</td>
<td>14.24%</td>
<td>$180.01M</td>
<td>23.57%</td>
</tr>
<tr>
<td>Tempus AI</td>
<td>Neutral</td>
<td>75.38%</td>
<td>$155.20M</td>
<td>-35.57%</td>
</tr>
<tr>
<td>Avantor</td>
<td>Neutral</td>
<td>-5.86%</td>
<td>$534.90M</td>
<td>1.07%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Revvity ranks at the bottom for Revenue Growth among its peers. It is also at the bottom for Gross Profit. However, Revvity is at the top for Return on Equity.</p>
<h3>About Revvity</h3>
<p>Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.</p>
<h3>Understanding the Numbers: Revvity's Finances</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Revvity's remarkable performance in 3 months is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of <strong>2.28%</strong>. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Revvity's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>6.35%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Revvity's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>0.55%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Revvity's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>0.34%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.44</strong>, Revvity adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<p><a href="https://www.benzinga.com/quote/RVTY/earnings"><strong>To track all earnings releases for Revvity visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


RVTY

A Glimpse of Revvity's Earnings Potential

<p>Evercore ISI Group  analyst Oliver Wintermantel   maintains Tractor Supply (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSCO#NASDAQ">TSCO</a>) with a In-Line and raises the price target from $60 to $65.</p>


TSCO

Evercore ISI Group Maintains In-Line on Tractor Supply, Raises Price Target to $65

<p>Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) will release its quarterly earnings report on Monday, 2025-07-28. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Celestica to report an <strong>earnings per share</strong> (EPS) of $1.17.</p>
<p>Celestica bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Overview of Past Earnings</h3>
<p>In the previous earnings release, the company beat EPS by $0.08, leading to a 3.35% drop in the share price the following trading session.</p>
<p>Here's a look at Celestica's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.12</td>
<td>1.06</td>
<td>0.93</td>
<td>0.81</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.20</td>
<td>1.11</td>
<td>1.04</td>
<td>0.91</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-3.0%</td>
<td>14.000000000000002%</td>
<td>18.0%</td>
<td>-4.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753452143_0.png" alt="eps graph" /></p>
<h3>Celestica Share Price Analysis</h3>
<p>Shares of Celestica were trading at $163.98 as of July 24. Over the last 52-week period, shares are up 232.24%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analysts' Take on Celestica</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Celestica.</p>
<p>A total of 9 analyst ratings have been received for Celestica, with the consensus rating being Outperform. The average one-year price target stands at $135.22, suggesting a potential 17.54% downside.</p>
<h3>Comparing Ratings with Competitors</h3>
<p>The analysis below examines the analyst ratings and average 1-year price targets of Flex, Jabil and Fabrinet, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Flex, with an average 1-year price target of $53.67, suggesting a potential 67.27% downside.</li>
<li>Analysts currently favor an Buy trajectory for Jabil, with an average 1-year price target of $218.33, suggesting a potential 33.14% upside.</li>
<li>Analysts currently favor an Buy trajectory for Fabrinet, with an average 1-year price target of $267.83, suggesting a potential 63.33% upside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
<p>In the peer analysis summary, key metrics for Flex, Jabil and Fabrinet are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Celestica</td>
<td>Outperform</td>
<td>19.91%</td>
<td>$273.90M</td>
<td>4.99%</td>
</tr>
<tr>
<td>Flex</td>
<td>Outperform</td>
<td>3.71%</td>
<td>$563M</td>
<td>4.44%</td>
</tr>
<tr>
<td>Jabil</td>
<td>Buy</td>
<td>15.71%</td>
<td>$681M</td>
<td>16.80%</td>
</tr>
<tr>
<td>Fabrinet</td>
<td>Buy</td>
<td>19.17%</td>
<td>$102.18M</td>
<td>4.34%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Celestica ranks at the bottom for Revenue Growth and Gross Profit, with the lowest values among peers. However, it has the highest Return on Equity, outperforming all others. Overall, Celestica's performance is mixed compared to its peers.</p>
<h3>About Celestica</h3>
<p>Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity &amp; Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, The Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity &amp; Cloud Solutions segment.</p>
<h3>Financial Insights: Celestica</h3>
<p><strong>Market Capitalization Highlights:</strong> Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.</p>
<p><strong>Revenue Growth:</strong> Celestica's remarkable performance in 3 months is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of <strong>19.91%</strong>. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> Celestica's net margin is impressive, surpassing industry averages. With a net margin of <strong>3.25%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Celestica's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>4.99%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Celestica's ROA excels beyond industry benchmarks, reaching <strong>1.46%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>0.6</strong>, caution is advised due to increased financial risk.</p>
<p><a href="https://www.benzinga.com/quote/CLS/earnings"><strong>To track all earnings releases for Celestica visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


What's Next: Celestica's Earnings Preview

WIIM

Hexcel shares are trading lower following Q2 reported financial results.

<p>Woodward (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) will release its quarterly earnings report on Monday, 2025-07-28. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Woodward to report an <strong>earnings per share</strong> (EPS) of $1.63.</p>
<p>The announcement from Woodward is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Performance in Previous Earnings</h3>
<p>Last quarter the company beat EPS by $0.23, which was followed by a 1.86% increase in the share price the next day.</p>
<p>Here's a look at Woodward's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.46</td>
<td>1.18</td>
<td>1.25</td>
<td>1.51</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.69</td>
<td>1.35</td>
<td>1.41</td>
<td>1.63</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>2.0%</td>
<td>-2.0%</td>
<td>4.0%</td>
<td>-17.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753452131_0.png" alt="eps graph" /></p>
<h3>Tracking Woodward's Stock Performance</h3>
<p>Shares of Woodward were trading at $255.245 as of July 24. Over the last 52-week period, shares are up 38.08%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analysts' Take on Woodward</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Woodward.</p>
<p>A total of 8 analyst ratings have been received for Woodward, with the consensus rating being Buy. The average one-year price target stands at $249.75, suggesting a potential 2.15% downside.</p>
<h3>Comparing Ratings with Peers</h3>
<p>The analysis below examines the analyst ratings and average 1-year price targets of Textron, AeroVironment and ATI, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Textron, with an average 1-year price target of $84.8, suggesting a potential 66.78% downside.</li>
<li>Analysts currently favor an Buy trajectory for AeroVironment, with an average 1-year price target of $266.1, suggesting a potential 4.25% upside.</li>
<li>Analysts currently favor an Outperform trajectory for ATI, with an average 1-year price target of $105.0, suggesting a potential 58.86% downside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
<p>The peer analysis summary provides a snapshot of key metrics for Textron, AeroVironment and ATI, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Woodward</td>
<td>Buy</td>
<td>5.78%</td>
<td>$240.10M</td>
<td>4.79%</td>
</tr>
<tr>
<td>Textron</td>
<td>Neutral</td>
<td>5.45%</td>
<td>$634M</td>
<td>2.86%</td>
</tr>
<tr>
<td>AeroVironment</td>
<td>Buy</td>
<td>39.63%</td>
<td>$100.33M</td>
<td>1.91%</td>
</tr>
<tr>
<td>ATI</td>
<td>Outperform</td>
<td>9.73%</td>
<td>$235.80M</td>
<td>5.21%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Woodward ranks at the top for Revenue Growth with 5.78%. It is in the middle for Gross Profit at $240.10M. Woodward is at the top for Return on Equity with 4.79%.</p>
<h3>Get to Know Woodward Better</h3>
<p>Woodward Inc is an independent designer, manufacturer, and service provider of control solutions for the aerospace and industrial markets. It designs, produces, and services reliable, efficient, low-emission, and high-performance energy control products for diverse applications in challenging environments. The company operates in two segments, Aerospace and Industrial. The Aerospace segment provides fuel pumps, actuators, air valves, specialty valves, fuel nozzles, and thrust reverser actuation systems for turbine engines and nacelles, and flight deck controls, actuators, servo controls, motors, and sensors for aircraft. The Industrial segment offers actuators, valves, pumps, fuel injection systems, solenoids, ignition systems, speed controls, electronics and software, and sensors.</p>
<h3>Financial Milestones: Woodward's Journey</h3>
<p><strong>Market Capitalization Analysis:</strong> Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Woodward showcased positive performance, achieving a revenue growth rate of <strong>5.78%</strong> as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> Woodward's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>12.33%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Woodward's ROE excels beyond industry benchmarks, reaching <strong>4.79%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Woodward's ROA excels beyond industry benchmarks, reaching <strong>2.48%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Woodward's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.4</strong>.</p>
<p><a href="https://www.benzinga.com/quote/WWD/earnings"><strong>To track all earnings releases for Woodward visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Uncovering Potential: Woodward's Earnings Preview

Trading Ideas

CREV

Carbon Revolution Public Shares Halted On Circuit Breaker To The Upside, Stock Now Up 41.7%

<p>Veralto (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLTO#NYSE">VLTO</a>) will release its quarterly earnings report on Monday, 2025-07-28. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Veralto to report an <strong>earnings per share</strong> (EPS) of $0.89.</p>
<p>The announcement from Veralto is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Historical Earnings Performance</h3>
<p>The company's EPS beat by $0.08 in the last quarter, leading to a 3.02% increase in the share price on the following day.</p>
<p>Here's a look at Veralto's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.87</td>
<td>0.89</td>
<td>0.85</td>
<td>0.80</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.95</td>
<td>0.95</td>
<td>0.89</td>
<td>0.85</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>3.0%</td>
<td>-5.0%</td>
<td>-5.0%</td>
<td>5.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753452121_0.png" alt="eps graph" /></p>
<h3>Performance of Veralto Shares</h3>
<p>Shares of Veralto were trading at $103.27 as of July 24. Over the last 52-week period, shares are down 1.53%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. </p>
<h3>Insights Shared by Analysts on Veralto</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Veralto.</p>
<p>Veralto has received a total of 4 ratings from analysts, with the consensus rating as Buy. With an average one-year price target of $107.5, the consensus suggests a potential 4.1% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>The below comparison of the analyst ratings and average 1-year price targets of Rollins, Clean Harbors and Tetra Tech, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Rollins, with an average 1-year price target of $64.0, suggesting a potential 38.03% downside.</li>
<li>Analysts currently favor an Buy trajectory for Clean Harbors, with an average 1-year price target of $262.67, suggesting a potential 154.35% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Tetra Tech, with an average 1-year price target of $37.0, suggesting a potential 64.17% downside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for Rollins, Clean Harbors and Tetra Tech, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Veralto</td>
<td>Buy</td>
<td>6.90%</td>
<td>$805M</td>
<td>10.37%</td>
</tr>
<tr>
<td>Rollins</td>
<td>Outperform</td>
<td>21.52%</td>
<td>$422.37M</td>
<td>10.11%</td>
</tr>
<tr>
<td>Clean Harbors</td>
<td>Buy</td>
<td>4.01%</td>
<td>$410.07M</td>
<td>2.28%</td>
</tr>
<tr>
<td>Tetra Tech</td>
<td>Neutral</td>
<td>5.63%</td>
<td>$214.18M</td>
<td>0.33%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Veralto ranks highest in Revenue Growth among its peers. It also leads in Gross Profit margin. However, it falls behind in Return on Equity, where another peer outperforms. Overall, Veralto is positioned well compared to its peers in terms of financial performance metrics.</p>
<h3>Unveiling the Story Behind Veralto</h3>
<p>Veralto is a diversified industrial firm organized into two segments, water quality as well as product quality and innovation. The water quality segment offers water analytics and water treatment solutions, while the product quality and innovation segment offers coding, packaging, and color solutions for consumer packaged goods and pharmaceuticals. Headquartered in Waltham, Massachusetts, the company has around 17,000 employees. Veralto generated approximately $5.2 billion in revenue in 2024.</p>
<h3>Financial Milestones: Veralto's Journey</h3>
<p><strong>Market Capitalization Analysis:</strong> Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.</p>
<p><strong>Revenue Growth:</strong> Veralto's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately <strong>6.9%</strong>. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> Veralto's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>16.89%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Veralto's ROE excels beyond industry benchmarks, reaching <strong>10.37%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Veralto's ROA excels beyond industry benchmarks, reaching <strong>3.45%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Veralto's debt-to-equity ratio is below the industry average. With a ratio of <b>1.14</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<p><a href="https://www.benzinga.com/quote/VLTO/earnings"><strong>To track all earnings releases for Veralto visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


VLTO

Earnings Preview: Veralto

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>Tesla</strong>.</p>
<p>Looking at options history for Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) we detected 389 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 48% of the investors opened trades with bullish expectations and 38% with bearish.</p>
<p>From the overall spotted trades, 85 are puts, for a total amount of $10,815,685 and 304, calls, for a total amount of $21,867,154.</p>
<h3>Expected Price Movements</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $265.0 and $520.0 for Tesla, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Tesla's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Tesla's substantial trades, within a strike price spectrum from $265.0 to $520.0 over the preceding 30 days.</p>
<h3>Tesla Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753452110_0_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/25/25</td>
<td>$2.59</td>
<td>$2.55</td>
<td>$2.55</td>
<td>$312.50</td>
<td>$224.1K</td>
<td>8.4K</td>
<td>53.6K</td>
</tr>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/01/25</td>
<td>$19.6</td>
<td>$19.5</td>
<td>$19.55</td>
<td>$330.00</td>
<td>$205.9K</td>
<td>2.1K</td>
<td>501</td>
</tr>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/25/25</td>
<td>$4.05</td>
<td>$3.95</td>
<td>$4.02</td>
<td>$310.00</td>
<td>$119.9K</td>
<td>17.3K</td>
<td>56.6K</td>
</tr>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/25/25</td>
<td>$3.75</td>
<td>$3.7</td>
<td>$3.75</td>
<td>$310.00</td>
<td>$108.3K</td>
<td>17.3K</td>
<td>55.7K</td>
</tr>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/25/25</td>
<td>$3.55</td>
<td>$3.5</td>
<td>$3.55</td>
<td>$310.00</td>
<td>$97.0K</td>
<td>17.3K</td>
<td>53.9K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Tesla</h3>
<p>Tesla is a vertically integrated battery electric vehicle automaker and developer of autonomous driving software. The company has multiple vehicles in its fleet, which include luxury and midsize sedans, crossover SUVs, a light truck, and a semi truck. Tesla also plans to begin selling more affordable vehicles, a sports car, and offer a robotaxi service. Global deliveries in 2024 were a little below 1.8 million vehicles. The company sells batteries for stationary storage for residential and commercial properties including utilities and solar panels and solar roofs for energy generation. Tesla also owns a fast-charging network.</p>
<p>Following our analysis of the options activities associated with Tesla, we pivot to a closer look at the company's own performance.</p>
<h3>Present Market Standing of Tesla</h3>
<ul>
<li>Currently trading with a volume of 16,434,974, the TSLA's price is up by 1.61%, now at $310.2. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 89 days.</li>
</ul>
<h3>What The Experts Say On Tesla</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $228.81.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from B of A Securities has decided to maintain their Neutral rating on Tesla, which currently sits at a price target of $341.<br />
&#x2A; Reflecting concerns, an analyst from GLJ Research lowers its rating to Sell with a new price target of $19.<br />
&#x2A; Consistent in their evaluation, an analyst from Goldman Sachs keeps a Neutral rating on Tesla with a target price of $315.<br />
&#x2A; An analyst from HSBC has revised its rating downward to Reduce, adjusting the price target to $120.<br />
&#x2A; Reflecting concerns, an analyst from China Renaissance lowers its rating to Hold with a new price target of $349.</p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Tesla, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Markets

TSLA

Tesla Unusual Options Activity For July 25

<p>Brown &amp; Brown (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRO#NYSE">BRO</a>) is gearing up to announce its quarterly earnings on Monday, 2025-07-28. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Brown &amp; Brown will report an <strong>earnings per share</strong> (EPS) of $0.99.</p>
<p>The announcement from Brown &amp; Brown is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Overview of Past Earnings</h3>
<p>In the previous earnings release, the company missed EPS by $0.01, leading to a 6.0% drop in the share price the following trading session.</p>
<p>Here's a look at Brown &amp; Brown's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.30</td>
<td>0.77</td>
<td>0.87</td>
<td>0.88</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.29</td>
<td>0.86</td>
<td>0.91</td>
<td>0.93</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-6.0%</td>
<td>-3.0%</td>
<td>2.0%</td>
<td>5.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753452110_0.png" alt="eps graph" /></p>
<h3>Performance of Brown &amp; Brown Shares</h3>
<p>Shares of Brown &amp; Brown were trading at $102.78 as of July 24. Over the last 52-week period, shares are up 5.3%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Insights Shared by Analysts on Brown &amp; Brown</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Brown &amp; Brown.</p>
<p>Brown &amp; Brown has received a total of 8 ratings from analysts, with the consensus rating as Underperform. With an average one-year price target of $114.38, the consensus suggests a potential 11.29% upside.</p>
<h3>Comparing Ratings with Peers</h3>
<p>The below comparison of the analyst ratings and average 1-year price targets of Willis Towers Watson and Baldwin Insurance, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Willis Towers Watson, with an average 1-year price target of $346.67, suggesting a potential 237.29% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Baldwin Insurance, with an average 1-year price target of $43.0, suggesting a potential 58.16% downside.</li>
</ul>
<h3>Peers Comparative Analysis Summary</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for Willis Towers Watson and Baldwin Insurance, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brown &amp; Brown</td>
<td>Underperform</td>
<td>11.96%</td>
<td>$702M</td>
<td>4.94%</td>
</tr>
<tr>
<td>Willis Towers Watson</td>
<td>Outperform</td>
<td>-5.04%</td>
<td>$899M</td>
<td>2.92%</td>
</tr>
<tr>
<td>Baldwin Insurance</td>
<td>Outperform</td>
<td>8.06%</td>
<td>$144.69M</td>
<td>2.32%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Brown &amp; Brown is positioned at the top for Revenue Growth among its peers. In terms of Gross Profit, it is also leading the group. However, it ranks in the middle for Return on Equity.</p>
<h3>Get to Know Brown &amp; Brown Better</h3>
<p>Brown &amp; Brown Inc is a diversified insurance agency, wholesale brokerage, insurance programs, and service. The Company markets and sells insurance products and services, in the property, casualty, and employee benefits areas. It provides customers with non-investment insurance contracts, as well as other targeted, customized risk management products and services. It has four reportable segments; the Retail segment; the Programs segment; the Wholesale Brokerage segment and; the Services segment. It generates the majority of its revenue from the Retail segment which provides insurance products and services to commercial, public and quasi-public, and Others through automobile dealer services F&amp;I businesses. Its geographic area is U.S., U.K., the Republic of Ireland, Canada, and Others.</p>
<h3>Brown &amp; Brown's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization Analysis:</strong> Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Brown &amp; Brown showcased positive performance, achieving a revenue growth rate of <strong>11.96%</strong> as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>23.61%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>4.94%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Brown &amp; Brown's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>1.9%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> Brown &amp; Brown's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.59</strong>.</p>
<p><a href="https://www.benzinga.com/quote/BRO/earnings"><strong>To track all earnings releases for Brown &amp; Brown visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


What's Next: Brown & Brown's Earnings Preview

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Adobe</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ADBE, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 8 uncommon options trades for Adobe.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 50% bullish and 37%, bearish.</p>
<p>Out of all of the special options we uncovered, 5 are puts, for a total amount of $646,370, and 3 are calls, for a total amount of $105,040.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $300.0 and $420.0 for Adobe, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In terms of liquidity and interest, the mean open interest for Adobe options trades today is 342.43 with a total volume of 34.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Adobe's big money trades within a strike price range of $300.0 to $420.0 over the last 30 days.</p>
<h3>Adobe Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753452105_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ADBE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/18/26</td>
<td>$45.15</td>
<td>$42.5</td>
<td>$43.29</td>
<td>$370.00</td>
<td>$207.7K</td>
<td>34</td>
<td align="right">0</td>
</tr>
<tr>
<td>ADBE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$41.35</td>
<td>$39.3</td>
<td>$40.79</td>
<td>$390.00</td>
<td>$195.7K</td>
<td>951</td>
<td align="right">0</td>
</tr>
<tr>
<td>ADBE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$61.95</td>
<td>$59.7</td>
<td>$60.85</td>
<td>$420.00</td>
<td>$121.6K</td>
<td>1.1K</td>
<td align="right">20</td>
</tr>
<tr>
<td>ADBE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/20/26</td>
<td>$43.9</td>
<td>$42.55</td>
<td>$42.91</td>
<td>$390.00</td>
<td>$85.8K</td>
<td>0</td>
<td align="right">20</td>
</tr>
<tr>
<td>ADBE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$139.4</td>
<td>$135.65</td>
<td>$138.87</td>
<td>$510.00</td>
<td>$69.4K</td>
<td>4</td>
<td align="right">5</td>
</tr>
</tbody>
</table>
</p>
<h3>About Adobe</h3>
<p>Adobe provides content creation, document management, and digital marketing and advertising software and services to creative professionals and marketers for creating, managing, delivering, measuring, optimizing, and engaging with compelling content multiple operating systems, devices, and media. The company operates with three segments: digital media content creation, digital experience for marketing solutions, and publishing for legacy products (less than 5% of revenue).</p>
<p>Having examined the options trading patterns of Adobe, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Where Is Adobe Standing Right Now?</h3>
<ul>
<li>With a volume of 108,012, the price of ADBE is down -0.44% at $370.07. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 48 days.</li>
</ul>
<h3>What Analysts Are Saying About Adobe</h3>
<p>A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $280.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Redburn Atlantic has revised its rating downward to Sell, adjusting the price target to $280. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Adobe, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


ADBE

What the Options Market Tells Us About Adobe

<p>High-rolling investors have positioned themselves bearish on SoFi Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>), and it's important for retail traders to take note.<br />
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in SOFI often signals that someone has privileged information.</p>
<p>Today, Benzinga's options scanner spotted 11 options trades for SoFi Technologies. This is not a typical pattern.</p>
<p>The sentiment among these major traders is split, with 36% bullish and 54% bearish. Among all the options we identified, there was one put, amounting to $209,220, and 10 calls, totaling $562,538.</p>
<h3>Expected Price Movements</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $13.0 to $25.0 for SoFi Technologies over the last 3 months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of SoFi Technologies stands at 12532.56, with a total volume reaching 4,695.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in SoFi Technologies, situated within the strike price corridor from $13.0 to $25.0, throughout the last 30 days.</p>
<h3>SoFi Technologies 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753452099_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>SOFI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/01/25</td>
<td>$0.95</td>
<td>$0.93</td>
<td>$0.95</td>
<td>$21.00</td>
<td>$209.2K</td>
<td>5.2K</td>
<td>2.4K</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.4</td>
<td>$3.35</td>
<td>$3.35</td>
<td>$22.00</td>
<td>$107.8K</td>
<td>18.8K</td>
<td>232</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$3.8</td>
<td>$3.75</td>
<td>$3.77</td>
<td>$25.00</td>
<td>$107.4K</td>
<td>28.6K</td>
<td>536</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$8.25</td>
<td>$8.2</td>
<td>$8.24</td>
<td>$14.00</td>
<td>$82.4K</td>
<td>4.4K</td>
<td>102</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$3.35</td>
<td>$3.35</td>
<td>$3.35</td>
<td>$22.00</td>
<td>$67.3K</td>
<td>18.8K</td>
<td>232</td>
</tr>
</tbody>
</table>
</p>
<h3>About SoFi Technologies</h3>
<p>SoFi is a financial-services company that was founded in 2011 and is based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020, the company also offers payment and account services for debit cards and digital banking.</p>
<h3>Current Position of SoFi Technologies</h3>
<ul>
<li>With a trading volume of 2,901,905, the price of SOFI is down by -0.95%, reaching $21.3.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 4 days from now.</li>
</ul>
<h3>What The Experts Say On SoFi Technologies</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $17.8.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Reflecting concerns, an analyst from TD Cowen lowers its rating to Hold with a new price target of $21.<br />
&#x2A; An analyst from Truist Securities has decided to maintain their Hold rating on SoFi Technologies, which currently sits at a price target of $20.<br />
&#x2A; In a cautious move, an analyst from JMP Securities downgraded its rating to Market Perform, setting a price target of $17.<br />
&#x2A; An analyst from Keefe, Bruyette &amp; Woods persists with their Underperform rating on SoFi Technologies, maintaining a target price of $13.<br />
&#x2A; An analyst from Barclays persists with their Equal-Weight rating on SoFi Technologies, maintaining a target price of $18. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for SoFi Technologies with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


SOFI

SoFi Technologies's Options: A Look at What the Big Money is Thinking

Press Releases

General

From Shoreline to Showstopper: ECD Reveals Vibrant Yellow Soft-Top Defender 90 "Beach Patrol"

ECD Unleashes Its Most Powerful Defender Yet

ECD Auto Design Unleashes '67 Ghost — The First in a New Line of Bespoke Custom Mustangs

U.S. Auto Manufacturer ECD Auto Design Reports First Quarter 2025 Financial Results

ECD Auto Design and Scheel-Mann Team Up to Elevate Classic Defender Comfort

ECD Auto Design Unveils an E-Type Like No Other – The Jaguar GTO

ECD Automotive Design Announces Key Initiatives to Right-Size Cost Structure and Support Disciplined Growth

Financing

ECD Automotive Design Secures $500M Equity Facility to Fund a Bitcoin Treasury

ECD Automotive Design Wins Dual Awards for Custom Jaguar E-Type and Mustang Builds

ECD Automotive Design's "Project Wilder" — A Powerful 700+ HP Supercharged California Land Rover Station Wagon

ECDA

AYRO

Cenntro

Chijet Motor Company, Inc. - Ordinary Shares

Chijet Motor Co

Envirotech Vehicles

Ford Motor

Faraday Future Intelligent Electric Inc. - Class A Common Stock

Faraday Future

Fly-E Group

General Motors

Honda Motor Co

Lucid Group

Li Auto Inc. - American Depositary Shares

Li Auto

Lotus Technology Inc. - American Depositary Shares

Lotus Technology

NIO Inc. American depositary shares, each representing one Class A ordinary share

NWTN

Polestar Automotive Holding UK Limited - Class A ADS

Polestar Automotive

Polestar Automotive Holding UK Limited - Class C-1 ADS (ADW)

Rivian Automotive, Inc. - Class A Common Stock

Rivian Automotive

Thor Industries

Toyota Motor

Tesla

VinFast Auto

Winnebago Industries

Workhorse Gr

XPeng Inc. American depositary shares, each representing two Class A ordinary shares

XPeng

ZEEKR Intelligent Technology Holding Limited American Depositary Shares (each representing ten (10) Ordinary Shares)

Comments

ECD Automotive Design

ECD Automotive Design (ECDA) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO